Homepage | RMD Open | A leading rheumatology journal from …
WEBRMD Open. RMD Open publishes high quality peer-reviewed original research covering the full spectrum of musculoskeletal disorders, rheumatism and connective tissue diseases, including osteoporosis, spine and rehabilitation. Clinical and epidemiological research, basic and translational medicine, interesting clinical cases, and smaller studies ...
Authors | RMD Open | A leading rheumatology journal from …
WEBRMD Open is an open access journal and levies an Article Processing Charge (APC) of 2,163 GBP (exclusive of VAT for UK and EU authors). The APC for Letters is 1,082 GBP. There are no submission, colour or page charges. There is a 25% discount for articles where the corresponding author has reviewed for RMD Open within the previous 12 months. A 50% discount on the standard APC will apply to ...
Health technology assessment: a framework - RMD Open
WEBIn a time where there is growing pressure on healthcare budgets, there is increased scrutiny of new health technologies, their effectiveness, safety and costs.1 It is in this context that Health Technology Assessment (HTA) has become increasingly important. The purpose of HTA is to provide policymakers with evidence to inform decision-making and develop guidance on the reimbursement and ...
WEBORIGINAL ARTICLE DAS28-CRP and DAS28-ESR cut-offs for high disease activity in rheumatoid arthritis are not interchangeable Roy M Fleischmann,1 Désirée van der Heijde,2 Philip V Gardiner,3 Annette Szumski,4 Lisa Marshall,5 Eustratios Bananis5 To cite: Fleischmann RM,
Reactive arthritis after SARS-CoV-2 infection - RMD Open
WEBSARS-CoV-2 has been recognised as a potential trigger of inflammatory arthritis in individuals with inflammatory rheumatic diseases as well as in previously unaffected individuals. However, new-onset arthritis after COVID-19 is a heterogeneous phenomenon that complicates differential diagnosis. For example, acute arthritis with features of viral arthritis has been reported after COVID-19, as ...
WEBCiurea A et al. RMD Open 20228:e002067 doi:101136rmdopen2021002067 1 ORIGINAL RESEARCH Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit
WEBSweet et al. RMD Open 20217:e001679 doi:101136rmdopen2021001679 1 ORIGINAL RESEARCH Guselkumab induces robust reduction in acute phase proteins and type 17 effector cytokines in active psoriatic
Diagnostic accuracy of serum biomarkers to identify giant cell ...
WEBIntroduction Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are frequently overlapping conditions. Unlike in GCA, vascular inflammation is absent in PMR. Therefore, serum biomarkers reflecting vascular remodelling could be used to identify GCA in cases of apparently isolated PMR. Materials and methods 45 patients with isolated PMR and 29 patients with PMR/GCA overlap were included ...
Canada-Denmark MRI scoring system of the spine in patients
WEBObjective To validate the Canada-Denmark (CANDEN) MRI scoring system for the spine in axial spondyloarthritis with updated lesion definitions. Methods Lesion definitions in the CANDEN system were updated and illustrated by a consensus set of reference images. Sagittal spine MRIs of 40 patients with axial spondyloarthritis obtained at baseline and at week 52 after initiation of treatment with ...
Efficacy and safety of intra-articular therapies in rheumatic and ...
WEBObjective To summarise the evidence on intra-articular therapies (IAT) to inform the 2020 EULAR recommendations. Methods An overview of systematic reviews (SR) including randomised-controlled trials (RCTs) of IAT in adults with arthropathies was performed up to July 2020. Pain, function, and frequency of adverse events were the main efficacy and safety outcomes, respectively.